Denosumab – A New Medication in the Treatment of Postmenopausal Osteoporosis

Przeglad Menopauzalny - Poland
doi 10.5114/pm.2017.70581
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Termedia Sp. z.o.o.

Related search

A Review of the Efficacy and Safety of Denosumab in Postmenopausal Women With Osteoporosis

Therapeutic Advances in Musculoskeletal Disease
RheumatologyOrthopedicsSports Medicine
2011English

Denosumab Compared to Bisphosphonates to Treat Postmenopausal Osteoporosis: A Meta-Analysis

Journal of Orthopaedic Surgery and Research
SurgeryOrthopedicsSports Medicine
2018English

Effect of Denosumab on Trabecular Bone Score in Postmenopausal Women With Osteoporosis

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2017English

Denosumab: A Promising Drug for the Prevention and Treatment of Osteoporosis

Women's Health
Medicine
2006English

Effects of Denosumab on Bone Density, Mass and Strength in Women With Postmenopausal Osteoporosis

Therapeutic Advances in Musculoskeletal Disease
RheumatologyOrthopedicsSports Medicine
2015English

Persistence With Denosumab and Persistence With Oral Bisphosphonates for the Treatment of Postmenopausal Osteoporosis: A Retrospective, Observational Study, and a Meta-Analysis

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2015English

Monthly Risedronate for the Treatment of Postmenopausal Osteoporosis

Pharmaceutica Analytica Acta
2014English

Denosumab in the Treatment of Glucocorticoid-Induced Osteoporosis: A Systematic Review and Meta-Analysis

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2019English

Persistence and Adherence With Osteoporosis Medication and Re-Fracture in Women With Postmenopausal Osteoporosis in Taiwan

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy